Published in Lung on October 04, 2011
Intensive care unit and lung cancer: when should we intubate? J Thorac Dis (2013) 1.10
Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer. J Biomark (2015) 0.87
Exhaled breath analysis for lung cancer detection using ion mobility spectrometry. PLoS One (2014) 0.83
Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects. Int J Chron Obstruct Pulmon Dis (2015) 0.78
"One-stop shop" spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology. Int J Nanomedicine (2013) 0.77
Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects. Lung (2017) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Detection of lung cancer with volatile markers in the breath. Chest (2003) 3.09
Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94
Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.53
Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax (2009) 2.28
Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther (2006) 2.15
Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer (2009) 1.99
An investigation on electronic nose diagnosis of lung cancer. Lung Cancer (2009) 1.85
Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem (1985) 1.83
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer (2008) 1.80
Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res (2005) 1.68
Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin Chem Lab Med (2009) 1.64
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax (2007) 1.54
Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro. Cancer Cell Int (2008) 1.40
Detection of human metabolites using multi-capillary columns coupled to ion mobility spectrometers. J Chromatogr A (2005) 1.39
Increased breath biomarkers of oxidative stress in diabetes mellitus. Clin Chim Acta (2004) 1.25
Method for the collection and assay of volatile organic compounds in breath. Anal Biochem (1997) 1.24
A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer (2007) 1.23
Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer (2009) 1.21
Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Thorac Oncol (2008) 1.19
Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. Anticancer Res (2009) 1.18
Ion mobility spectrometry coupled with multi-capillary columns for metabolic profiling of human breath. J Breath Res (2009) 1.09
A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir Med (2009) 1.08
Ion mobility spectrometry in the diagnosis of sarcoidosis: results of a feasibility study. J Physiol Pharmacol (2007) 1.08
Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. Biomed Chromatogr (2009) 1.03
Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations. Lung Cancer (2007) 1.01
Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. Chest (2010) 0.98
Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst (2010) 0.93
Breath analysis in non small cell lung cancer patients after surgical tumour resection. Acta Biomed (2008) 0.89
Volatile organic compounds in the breath of patients with schizophrenia. J Clin Pathol (1995) 0.87
Autofluorescence bronchoscopy, a novel modality for the early detection of bronchial premalignant and malignant lesions. J Med Invest (2007) 0.86
Breath markers of oxidative stress in patients with unstable angina. Heart Dis (2003) 0.81
Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med (2015) 8.61
Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol (2008) 2.54
Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail (2006) 2.33
Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial. Am J Respir Crit Care Med (2013) 2.07
A novel extracorporeal CO(2) removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest (2013) 1.75
Validation and pilot clinical study of a new bronchoscopic method to measure collateral ventilation before endobronchial lung volume reduction. J Appl Physiol (1985) (2008) 1.49
Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure. Eur J Heart Fail (2013) 1.47
Detection of human metabolites using multi-capillary columns coupled to ion mobility spectrometers. J Chromatogr A (2005) 1.39
Elevated gamma-glutamyltransferase is associated with mortality in lung transplantation for cystic fibrosis. Transpl Int (2011) 1.39
Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy. J Cancer (2013) 1.31
Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m(2) combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer. Lung Cancer (2009) 1.21
Diagnostic performance of single airflow channel recording (ApneaLink) in home diagnosis of sleep apnea. Sleep Breath (2009) 1.21
Malignant pleural effusion and algorithm management. J Thorac Dis (2013) 1.09
Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders. Neuromuscul Disord (2003) 1.08
Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. J Clin Oncol (2007) 1.06
Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema--potential mechanisms, treatment algorithm, and case examples. Respiration (2014) 1.03
Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis. Cancer (2007) 1.02
Brucellosis of the lung: case report and review of the literature. Virchows Arch (2007) 0.98
Trimodality treatment in Stage III nonsmall cell lung carcinoma: prrognostic impact of K-ras mutations after neoadjuvant therapy. Cancer (2002) 0.97
Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer. Oncology (2008) 0.95
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center. Eur J Cancer (2013) 0.93
Therapeutic lung lavages in children and adults. Respir Res (2005) 0.92
[Nocturnal noninvasive ventilation of children and adolescents with neuromuscular diseases: effect on sleep and symptoms]. Wien Klin Wochenschr (2003) 0.92
Association of obstructive sleep apnoea with subclinical coronary atherosclerosis. Atherosclerosis (2013) 0.91
Cardiac autonomic function and cardiovascular response to exercise in patients with chronic obstructive pulmonary disease. COPD (2012) 0.89
Suicide Gene Therapy for Cancer - Current Strategies. J Genet Syndr Gene Ther (2013) 0.87
Cardiac autonomic dysfunction and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology (2011) 0.86
Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial. Int J Radiat Oncol Biol Phys (2009) 0.86
Validation of ApneaLink as screening device for Cheyne-Stokes respiration. Sleep (2009) 0.86
Avoidance of intubation during acute exacerbation of chronic obstructive pulmonary disease for a lung transplant candidate using extracorporeal carbon dioxide removal with the Hemolung. J Thorac Cardiovasc Surg (2013) 0.86
Pattern recognition of obstructive sleep apnoea and Cheyne-Stokes respiration. Physiol Meas (2008) 0.85
Technical advances: measurement of collateral flow in the lung with a dedicated endobronchial catheter system. J Bronchology Interv Pulmonol (2009) 0.84
Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer. Future Oncol (2013) 0.84
Evaluation of a novel endobronchial ultrasound-guided lymph node forceps in enlarged mediastinal lymph nodes. Respiration (2013) 0.84
Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients. Future Oncol (2013) 0.83
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis. Onco Targets Ther (2013) 0.83
Optimized autofluorescence bronchoscopy using additional backscattered red light. J Biomed Opt (2007) 0.82
IPPB-assisted coughing in neuromuscular disorders. Pediatr Pulmonol (2006) 0.82
Research spotlight: sirolimus-coated stents for airway tracheal stenosis: a future 3D model concept with today's knowledge. Ther Deliv (2013) 0.82
Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation. J Heart Lung Transplant (2011) 0.82
Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer. Lung Cancer (2006) 0.81
Interaction of sleep disturbances and gastroesophageal reflux in chronic laryngitis. Am J Otolaryngol (2002) 0.81
Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics. Int J Pharm (2013) 0.81
Obstructive Sleep Apnea-a Perioperative Risk Factor. Dtsch Arztebl Int (2016) 0.81
Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup. Int J Pharm (2013) 0.80
Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems. Int J Pharm (2013) 0.80
Biodegradable Airway Stents - Bench to Bedside: A Comprehensive Review. Respiration (2015) 0.79
New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam. Int J Pharm (2013) 0.79
Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring. J Heart Lung Transplant (2005) 0.79
The effects of controlled breathing during pulmonary rehabilitation in patients with COPD. Respiration (2011) 0.79
"One-stop shop" spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology. Int J Nanomedicine (2013) 0.77
Endobronchial phototoxicity of WST 09 (Tookad), a new fast-acting photosensitizer for photodynamic therapy: preclinical study in the pig. Photochem Photobiol (2003) 0.77
Determining the prevalence and predictors of sleep disordered breathing in patients with chronic heart failure: rationale and design of the SCHLA-HF registry. BMC Cardiovasc Disord (2014) 0.77
PDT in early central lung cancer. Thorax (2007) 0.76
Improvement of the specificity of cancer detection by autofluorescence imaging in the tracheo-bronchial tree using backscattered violet light. Photodiagnosis Photodyn Ther (2008) 0.76
Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. N Engl J Med (2016) 0.75
Changes in lung function parameters after wedge resections: a prospective evaluation of patients undergoing metastasectomy. Chest (2012) 0.75
Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology (2003) 0.75
Hemoptysis in primary pulmonary amyloidoma treated with intrabronchial arterial coiling. Am J Respir Crit Care Med (2014) 0.75
Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Low-FEV1 Patients. Respiration (2016) 0.75
Tumor regression and sirolimus-based therapy in lung transplantation. J Heart Lung Transplant (2013) 0.75
[Sleep apnea--treatment improves hypertension]. Med Klin (Munich) (2006) 0.75
Simulations and experiments of the balloon dilatation of airway stenoses. Biomed Tech (Berl) (2009) 0.75
High-level expression of matrix-associated transforming growth factor-beta1 in benign airway stenosis. Chest (2006) 0.75
Viscoelasticity of the trachea and its effects on flow limitation. J Appl Physiol (1985) (2005) 0.75
Prospects of gene therapy for pulmonary diseases: progress and limitations. Med Chem (2017) 0.75
Sleep disorders and alcohol. Sleep Med Rev (2002) 0.75
Biofilm Formation in a Permanent Tracheal Stent Implanted for Twenty-Five Years. Respiration (2015) 0.75
Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series. Nephrol Dial Transplant (2011) 0.75
The electrosurgical knife in an optimized intermittent cutting mode for the endoscopic treatment of benign web-like tracheobronchial stenosis. Arch Bronconeumol (2011) 0.75